CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2024

COO 11.12.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-05
Name of Upcoming Event:N/A
Full Press ReleaseSEC FilingsOur COO Tweets

About Gravity Analytica

Recent News

  • 03.06.2025 - Q1 2025 CooperCompanies Earnings Conference Call
  • 01.14.2025 - J.P. Morgan Healthcare Conference
  • 12.17.2024 - CooperCompanies to Present at the J.P. Morgan Healthcare Conference

Recent Filings

  • 01.10.2025 - 4 Statement of changes in beneficial ownership of securities
  • 12.06.2024 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]

SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) --CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The dial-in number for the call is 800-715-9871 and the conference ID is 2026064. A simultaneous audio webcast and subsequent replay can be accessed athttp://investor.coopercos.com.

About CooperCompaniesCooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visitwww.coopercos.com.

Contact:Kim DuncanVice President, Investor Relations and Risk Management925-460-3663ir@cooperco.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com